Psyence Biomedical Ltd

CUSIP 74449F308COMQ4 2025

Psyence Biomedical Ltd — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

16.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 19, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 19, 2026	Weiner Jeffrey David	13G	5.1%	51.9K	SEC
2	Jan 13, 2026	Kaos Capital Ltd.	13D/A	4.9%	—	SEC
3	Dec 10, 2025	Kaos Capital Ltd.	13D	16.8%	—	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Bank Of America Corp /De/	3.3K	$2.5K
2	Ubs Group AG	1.0K	$758
3	Stonehage Fleming Financial Services Holdings Ltd	561	$422
4	Virtu Financial LLC	37.0K	$28